Bioartificial Brain Slices for Drug Screening

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$599,889.00
Award Year:
2013
Program:
SBIR
Phase:
Phase I
Contract:
1R43MH099721-01A1
Award Id:
n/a
Agency Tracking Number:
R43MH099721
Solicitation Year:
2013
Solicitation Topic Code:
NIMH
Solicitation Number:
PA11-133
Small Business Information
185 ALLEN BROOK LN, STE 201, WILLISTON, VT, -
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
787008242
Principal Investigator:
PAULANGSTMAN
(802) 288-9290
paul@mbfbioscience.com
Business Contact:
JACOBGLASER
(802) 288-9290
jack@mbfbioscience.com
Research Institute:
Stub




Abstract
DESCRIPTION (provided by applicant): It has become evident that the microvasculature (i.e., the vasculature visible at the light microscopic level) plays a critical role in the plasticity of he brain under various physiological and pathological conditions,including fundamental processes in neuroplasticity such as axonal, dendritic and synaptic plasticity during brain development, learning, recovery from traumatic brain injury and brain inflammation, aging and neurodegeneration, as well as during neurogenesis (i.e., the generation of new neurons) and the migration of neuronal precursors (to their final destination in the brain). Accordingly, investigators have attempted for more than 30 years to trace, reconstruct, visualize and quantitatively characterize the microscopic three-dimensional (3D) micro-angioarchitecture of the brain in normal and pathological tissue (3D microangioarchitectonics). However, there has been very little use of 3D microangioarchitectonics in neuroscience research. This is due to thepaucity of tools to study 3D microangioarchitectonics. We therefore propose to create Vesselucida, an innovative software product to perform advanced, interactive and automatic 3D microangioarchitectonics in normal and pathological brain tissue. This system will allow significant advancements in studies addressing the roles of microvessels on various aspects of neuroplasticity in neuroscience research, as well as in pharmacological and biotechnology research and development as the basis for the developmentof innovative treatments to fight complex brain diseases. Accordingly, the development of Vesselucida represents clear progress beyond the state-of-the-art, with great benefits for the neuroscience research community and society in general. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: The proposed project will enable important new research, which is currently not feasible, into the critical role of the microvasculature in the plasticity o the brain under various physiological and pathologicalconditions (such as brain development, learning, recovery from traumatic brain injury and brain inflammation, aging and neurodegeneration). To achieve this aim, the proposed project will develop and commercialize an innovative image analysis system to permit interactive and automatic reconstruction of the blood vessel network in normal and pathological brain tissue at the light microscopic level. This system will open new horizons in studies addressing the roles of microvessels on various aspects of neuroplasticity in neuroscience research, as well as in pharmacological and biotechnology research and development as the basis for the development of innovative treatments to fight complex brain diseases.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government